New Rhode Island lab to develop vaccines

Researchers at the newly formed Institute for Immunology and Informatics at the University of Rhode Island will focus on developing vaccines for diseases that are rampant in poor countries, including malaria, dengue fever, AIDS and tuberculosis, using a "genome-to-vaccine" approach. The institute will have access to the bioinformatics tools of biotech firm EpiVax in exchange for partial rights to potential disease-prevention discoveries.

View Full Article in:

Providence Journal (R.I.) (free registration), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice President of Finance
Urban Health Plan, Inc.
Bronx, NY
Director of Payor/Provider Contracting
U.S. Medical Management
Tryo, MI
Director, Corporate Counsel - Regulatory Law
Regeneron
Tarrytown, NY
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
Active Implantable Medical Device (AIMD) Product Expert
BSI
Nationwide, SL_Nationwide